Today on Outsourcing-Pharma.com   Clinical trials in emerging regions: where is best? India's Indoco pursuing the West Kinaxo adds new proteomics service Cosmo lands partner for world-first drug Avecia takes on new MS drug

Related Industry News   GSK, Synta join forces in billion dollar cancer deal FDA backs tablet imaging tech Last throw of the dice for NPS Pharmaceuticals? Three more nailed in fake drugs scandal

Breaking News on Outsourcing Pharma
Daily  Thursday 11 October 2007		Forward to a colleague

	Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Access Full Stories Clinical trials in emerging regions: where is best? There is much confusion over the competing lure of the four major emerging regions for clinical trials, although each have their pros and cons... Read India's Indoco pursuing the West Indian contract formulations specialist Indoco has been actively angling itself to compete more heartily in the western market... Read Kinaxo adds new proteomics service Kinaxo Biotechnologies is now offering a new proteomics service to help drug developers decide which drug candidates to move through the preclinical process... Read Cosmo lands partner for world-first drug Italian firm Cosmo Pharmaceuticals today announced a licensing agreement with Ferring for its reformulated budesonide product, predicted to be the first oral corticosteroid for ulcerative colitis approved worldwide... Read Avecia takes on new MS drug Avecia Biologics has signed a development and manufacturing deal with US firm BaroFold, making use of the company's protein processing technology to produce its lead interferon-based multiple sclerosis (MS) candidate... Read
	All News Headlines for: October | September | August
	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here
	Related Industry News GSK, Synta join forces in billion dollar cancer deal GlaxoSmithKline (GSK) has signed a deal worth around a billion dollars with US biopharma firm Synta, over its first-in-class melanoma drug, a notoriously difficult cancer to treat... Read FDA backs tablet imaging tech UK-based TeraView has had its tablet imaging technology backed by the US Food and Drug Administration (FDA), following a study by the regulatory agency... Read Last throw of the dice for NPS Pharmaceuticals? NPS pharmaceuticals has ended its collaboration with pharma giant AstraZeneca, selling the rights to the partnership for $30m (€21.2m) in order to fund development of its late-stage products... Read Three more nailed in fake drugs scandal Three more individuals have been sentenced following last month's exposure of the largest counterfeit drugs conspiracy ever to be encountered in the UK... Read Weekly Comment FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials. Read Previous Headlines Pharmaceutical outsourcing: people on the move Kendle, Quintiles, Icon, and AMRI have all had people on the move in the world of pharmaceutical outsourcing. GSK and Pfizer have also made big personnel announcements... Read China luring preclinical players China is one of the best destinations to outsource preclinical work, delegates heard at this year's CPhI trade how in Milan... Read AMRI embraces India US-based contract manufacturer AMRI has been busily embracing India with the purchase and construction of infrastructure to cement itself in this popular location, delegates heard at this year's CPhI in Milan... Read RBM buys EDI, simplifies immune response testing Biomarker testing service provider Rules-Based Medicine (RBM) has bought EDI to gain access to its 3D organ-like and ex vivo cell culture test systems to aid its preclinical and clinical research programmes... Read Parexel purchases Taiwan firm Parexel has purchased a clinical research organisation (CRO) in Taiwan as a means to exert its presence in this industry's budding Asia-Pacific region... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com